Skip to content
Screener

Biote Corp. BTMD Q4 2025 Annual earnings

Reported March 11, 2026 · After market close

Revenue$46.4MBeat by $579.4K
EPS$0.06Beat by $0.01
Revenue estimate$45.8M
EPS estimate$0.05

Next report

Nov 4, 2026 (In 3 weeks)
Revenue estimate$44.0M
EPS estimate-$0.05

Financials

Q4 2025

Income statement

See full
Revenue$46.4M-6.9%
Gross profit$31.6M-11.8%
Operating income$6.8M+147%
Net income$2.0M-47.2%
EPS (diluted)$0.06-45.5%

Balance sheet

See full
Cash & equivalents$24.1M-38.7%
Total debt$104.9M-5.4%
Total equity-$58.5M+44.7%
Total assets$107.6M-12.1%

Cash flow

See full
Operating cash flow$7.6M-38.8%
CapEx$1.1M-35.5%
Free cash flow$6.5M-39.3%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$79.77M-58.5%
Enterprise value$160.57M-39.1%
P/E2.9×-58.0×
P/S0.4×-0.6×

Profitability

See full
Gross margin71.5%+0.9pp
Operating margin18.5%+2.5pp
Net margin14.1%+12.5pp
FCF margin15.7%-4.0pp

Returns & leverage

See full
Current ratio1.2×-0.1×

Segments

By product

See full
Product Revenue$45.3M-6.2%
Pellet Procedures Product Revenue$31.8M-13.0%
Dietary Supplements$11.7M+16.0%
Disposable Trocars Product Revenue$1.2M+7.7%
Other Service Revenue$583.0K-33.4%

FAQ

When did Biote Corp. report Q4 2025 earnings?
Biote Corp. (BTMD) reported Q4 2025 earnings on March 11, 2026 after market close.
What were Biote Corp.'s Q4 2025 revenue and EPS?
Biote Corp. reported revenue of $46.4M and eps of $0.06 for Q4 2025.
Did Biote Corp. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $45.8M by $579.4K. EPS beat the consensus estimate of $0.05 by $0.01.
How did Biote Corp.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 6.9% from $49.8M a year earlier and eps declined 40.0% from $0.10.
Where can I find Biote Corp.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-102129) and the 10-K periodic report (0001193125-26-106099) directly on SEC EDGAR. The filing index links above go to sec.gov.